Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1993 of 5804
-
Taiwan launches genetic map for bile duct cancer
Knowledge-focused OngoingRecent progress in comprehensive genomic profiling for advanced BTC has helped to clarify tumorigenesis and facilitate the coming era of precision medicine. To further elucidate the underlying molecular genomic aberrations, as well as the clinical demographics and therapeutic out…
Sponsor: National Health Research Institutes, Taiwan • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Can online therapy and a buddy help beat addiction?
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy and cost-effectiveness of Breaking Free Online, in a comparison of outpatients seeking treatment for substance use disorder who receive standard care with group peer support, versus with access to Breaking Free Online, versus …
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New scan spots hidden thyroid tumors that resist standard treatment
Diagnosis Recruiting nowBackground: About 5% to 10% of differentiated thyroid cancers become resistant to standard treatment with radioactive iodine. In these cases, treatment options are limited and generally not effective. Researchers want to see if they can better detect thyroid tumors by using a co…
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Cooling therapy may shield brain after CO poisoning
Disease control CompletedThis randomized trial will investigate important neurocognitive clinical outcomes of patients with acute severe carbon monoxide poisoning (ASCOP) randomized to receive either therapeutic hypothermia or normothermia combined with hyperbaric oxygen therapy (HBO).
Phase: NA • Sponsor: Wonju Severance Christian Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Antibody shield for the vulnerable: COVID-19 prevention trial in immunocompromised
Prevention TerminatedThe primary objective of the study is to evaluate the effect of casirivimab+imdevimab, compared with placebo, in preventing symptomatic SARS-CoV-2 infection in immunocompromised participants. The secondary objectives of the study are: * To evaluate the safety and tolerability o…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC
-
Can donor stem cells help intestinal transplant patients ditch heavy meds?
Disease control Recruiting nowThe purpose of this study is to investigate the safety and feasibility of giving intestinal transplant patients CD34+ stem cells (the cells that make all the types of blood cells) obtained from their organ donor's bone marrow. The goal of this is to develop a post-transplant trea…
Phase: PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Psoriasis patients see Real-World quality of life gains with brodalumab
Symptom relief OngoingThis is a phase IV, 12-month observational, prospective, open-label, multi-center study that will be conducted across approximately 50 sites in Canada for an estimated study duration of 32 months. All eligible adult participants who are enrolling into the SILIQ Patient Support Pr…
Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New hope for stubborn nasal polyps: dupilumab shows promise
Disease control CompletedThis was a Phase 4, open-label, single-arm, multicenter study to evaluate the efficacy and safety of dupilumab subcutaneous (SC) injection monotherapy in Japanese participants aged 18 or older with CRSwNP that is not adequately controlled with existing therapies. Duration of stu…
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 16:37 UTC
-
New combo may speed stem cell harvest for myeloma patients
Disease control CompletedThis is a single-group treatment, phase IV, open label study to assess the mobilization efficacy and safety of plerixafor in combination with G- CSF in male and female participants from 18 to 75 years of age with multiple myeloma for autologous transplantation. Study Duration-Scr…
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New MRI scan could replace risky heart catheterization for lung pressure diagnosis
Diagnosis CompletedDue to radiation exposure and low but real risk of morbidity and mortality associated with right heart catheterization, non-invasive procedures to estimate mPAP are desired for the diagnosis of PH or to monitor treatment effectiveness. Echocardiography is used as a screening tool…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Scientists probe hidden resistance in prostate cancer radiation treatment
Knowledge-focused Recruiting nowThis is a multicenter, correlative study to existing Lutetium based prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) trials and uses.
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Cancer pain study questions need for extra paracetamol pills
Symptom relief CompletedCurrent guidelines recommend all people with cancer-related pain should be prescribed paracetamol, even those receiving high doses of strong pain killers (opioids) such as morphine. Although this has been shown in studies to be beneficial in other conditions, for instance dental …
Phase: PHASE3 • Sponsor: Oslo University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Coffee vs. AFib: can ditching your morning cup keep your heart in rhythm?
Disease control CompletedGiven both the increasing population impact of atrial fibrillation (AF) and the widespread consumption of coffee in society, determining an associated benefit or risk of coffee consumption on AF is of great clinical relevance. This study will evaluate the effect of randomly assig…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New balloon could unclog heart stents without extra metal
Disease control CompletedThe goal of this first in human study is to assess the safety and inhibition of restenosis of the CVT Everolimus-coated PTCA Catheter in the treatment of subjects presenting in-stent restenotic lesions in native coronary arteries.
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for stubborn high blood pressure: drug targets blood vessels
Disease control Recruiting nowThe management of patients with resistant arterial hypertension, who are characterized by a very high cardiovascular risk, remains a major therapeutic issue. The use of endothelin-1 (ET-1) receptor antagonists, in addition to lowering blood pressure, may also improve endothelial …
Phase: PHASE2 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Heart showdown: which procedure boosts CRT best for AF and heart failure?
Disease control Recruiting now70 patients with heart failure, AF and CRT with BiV\<95% will be randomised to either AF ablation or AV node ablation. Evaluation at 6 months with echocardiography and clinical assessment.
Phase: NA • Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Eat by the clock: new study tests Time-Restricted feeding for menopause belly fat
Disease control Recruiting nowThis is a randomized, parallel two-arm clinical trial design to study the efficacy of time-restricted feeding on metabolic risk in postmenopausal women, who may be particularly vulnerable to disruption of circadian eating rhythms and the associated metabolic dysfunction. It is hy…
Phase: NA • Sponsor: Julie Pendergast • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Psilocybin without the trip: scientists hunt for a microdose that skips hallucinations
Knowledge-focused CompletedThis randomized, double-blind, placebo-controlled, single ascending dose study will evaluate psilocybin in healthy adult subjects. Each subject will complete Screening within 28 days before admission, a 3-day/2-night inpatient Treatment Phase from Day -1 to Day 2, and Follow-Up 7…
Phase: PHASE1 • Sponsor: Diamond Therapeutics Inc. • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Can tiny acupuncture needles boost fertility in women with low egg supply?
Disease control CompletedUsing a multi-center, large sample, randomized, patient-assessor blinded, sham-controlled clinical trial to evaluate the effect of thumbtack needle (TN) on ovarian function of patients with diminished ovarian reserve (DOR).
Phase: NA • Sponsor: Dongmei Huang • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Children with Crohn's, colitis, or psoriatic arthritis get long-term safety check on stelara
Disease control OngoingThe purpose of this study is to collect long-term safety data of subcutaneous (SC) ustekinumab
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC